Business Context and Reporting Period
Pavmed Inc., a Delaware corporation and emerging growth company, filed this Form 8-K on April 22, 2019. The report covers events occurring on April 22, 2019, and includes a press release dated April 24, 2019, regarding product development updates.
Key Financial Metrics
This filing does not provide revenue, profit, cash flow, margin, or liquidity metrics. The only financial data disclosed relates to a specific debt instrument:
- Debt Instrument: Senior Secured Convertible Note issued on December 27, 2018.
- Principal Amount: $7,750,000.
- Initial Conversion Price: $1.60 per share.
Material Changes
The Company elected to temporarily reduce the conversion price of its outstanding Senior Secured Convertible Note. Effective April 23, 2019, through May 14, 2019 (the "Adjustment Period"), the conversion price is reduced from $1.60 per share to the greater of:
- $1.00 per share, or
- 85% of the closing sale price of the common stock on the most recent trading day (recalculated daily).
Conversion at this reduced price is capped at 2,000,000 shares. Upon the end of the Adjustment Period or the conversion of 2,000,000 shares, whichever occurs first, the conversion price reverts to $1.60 per share.
Guidance, Outlook, and Risks
The filing includes a press release (Exhibit 99.1) providing an update on certain product developments, though specific details of these developments are not contained within the text of the 8-K itself. The filing notes that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the current market price of Pavmed Inc. common stock to calculate the effective conversion price during the Adjustment Period.
- Review the attached press release (Exhibit 99.1) for specific details on product development updates.
- Monitor the conversion activity to determine if the 2,000,000 share cap is reached before May 14, 2019.
- Confirm the terms of the Senior Secured Convertible Note regarding potential dilution upon conversion.